Ivermectin vs Value-Based Care: Patient Impact in 2025 U.S.
The US healthcare system is undergoing a transformative phase in 2025, propelled by value-based care (VB) models that prioritize patient outcomes and cost-efficiency over traditional fee-for-service payments. In this evolving landscape, ivermectin —a drug historically used for parasitic infections—has emerged as a significant player within value-based care strategies. This blog...
0 Commentarii
0 Distribuiri